Skip to main content
Premium Trial:

Request an Annual Quote

Percorso Inks Commercialization Deal with Generation Biotech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Percorso Life Sciences announced an agreement today to commercialize Generation Biotech's SNPSeq products and help develop its business.

Generation Biotech, based in Lawrenceville, NJ., develops tools for DNA analysis. According to a statement, its proprietary bead-based haplotype- and region-specific extraction technology allows for the sequence-specific isolation of DNA segments.

Terms of the deal were not disclosed.

Perscorso is a life science marketing and consulting firm based in Plymouth Meeting, Penn.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.